UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056402
Receipt number R000064435
Scientific Title Demonstration test for early detection of heart disease using a heart sound app
Date of disclosure of the study information 2024/12/09
Last modified on 2025/12/23 13:27:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Demonstration test for early detection of heart disease using a heart sound app

Acronym

Demonstration test for early detection of heart disease using a heart sound app

Scientific Title

Demonstration test for early detection of heart disease using a heart sound app

Scientific Title:Acronym

Demonstration test for early detection of heart disease using a heart sound app

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the relationship between data obtained from a heart sound app (made by Kokoromil) and underlying diseases or spontaneous stress levels

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Signs of atrial fibrillation, arrhythmia, and stress during the measurement period

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate
2.Persons who are 50 years old or more

Key exclusion criteria

1.Persons who were judged as inappropriate for study participants by the principal investigator

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Okaniwa

Organization

Kokoromil Co., Ltd.

Division name

Development Division

Zip code

160-0023

Address

Kanno Bld. 2F, 6-2-16, Nishi-shinjyuku,Shinjyuku-ku,, Tokyo, JAPAN

TEL

03-5323-0010

Email

t-okaniwa@kokoromil.com


Public contact

Name of contact person

1st name Shun
Middle name
Last name Yamada

Organization

Kokoromil Co., Ltd.

Division name

Solutions Division

Zip code

160-0023

Address

Kanno Bld. 2F, 6-2-16,Nishi-shinjyuku,Shinjyuku-ku,, Tokyo, JAPAN

TEL

03-5323-0010

Homepage URL


Email

s-yamada@kokoromil.com


Sponsor or person

Institute

Kokoromil Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kumamoto Prefectural Government

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 11 Month 24 Day

Date of IRB

2024 Year 11 Month 25 Day

Anticipated trial start date

2024 Year 12 Month 09 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2024 Year 12 Month 09 Day

Last modified on

2025 Year 12 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064435